{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:17:33Z","timestamp":1789611453177,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["546272"],"award-info":[{"award-number":["546272"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1092642"],"award-info":[{"award-number":["1092642"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ijcard.2018.01.077","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T11:45:22Z","timestamp":1520941522000},"page":"192-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction"],"prefix":"10.1016","volume":"258","author":[{"given":"Andrew R.","family":"Kompa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Krum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6801-1190","authenticated-orcid":false,"given":"Thomas G.","family":"von Lueder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9580-2548","authenticated-orcid":false,"given":"Bing H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.01.077_bb0005","first-page":"e29","article-title":"Heart disease and stroke statistics\u20132015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.01.077_bb0010","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jama.292.3.344","article-title":"Trends in heart failure incidence and survival in a community-based population","volume":"292","author":"Roger","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2018.01.077_bb0015","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa1514859","article-title":"Aliskiren, enalapril, or aliskiren and enalapril in heart failure","volume":"374","author":"McMurray","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0020","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCHEARTFAILURE.112.000289","article-title":"Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure","volume":"6","author":"von Lueder","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00109-011-0801-z","article-title":"Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides","volume":"90","author":"Calvieri","year":"2012","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.ijcard.2018.01.077_bb0030","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.114.013748","article-title":"Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure","volume":"131","author":"Packer","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.01.077_bb0040","doi-asserted-by":"crossref","first-page":"27909","DOI":"10.1038\/srep27909","article-title":"Structure of neprilysin in complex with the active metabolite of sacubitril","volume":"6","author":"Schiering","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCHEARTFAILURE.114.001785","article-title":"Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy","volume":"8","author":"von Lueder","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0050","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2015.03.116","article-title":"Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis","volume":"186","author":"Wang","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0055","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0060","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0065","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1124\/jpet.107.133546","article-title":"Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction","volume":"325","author":"Kompa","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083687","article-title":"The uremic toxin adsorbent AST-120 abrogates cardiorenal injury following myocardial infarction","volume":"8","author":"Lekawanvijit","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2018.01.077_bb0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0091270009343932","article-title":"Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi)","volume":"50","author":"Gu","year":"2010","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0080","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/FJC.0000000000000128","article-title":"Effects of PP1-12, a novel protein phosphatase-1 inhibitor, on ventricular function and remodeling after myocardial infarction in rats","volume":"64","author":"He","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0085","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/00005344-199612000-00003","article-title":"Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction","volume":"28","author":"Duncan","year":"1996","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0090","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ejhf.474","article-title":"LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice","volume":"18","author":"Suematsu","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0095","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.ijcard.2012.12.065","article-title":"Subtotal nephrectomy accelerates pathological cardiac remodeling post-myocardial infarction: implications for cardiorenal syndrome","volume":"168","author":"Liu","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/1071-9164(95)90019-5","article-title":"Rat infarct model of myocardial infarction and heart failure","volume":"1","author":"Goldman","year":"1995","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0105","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cardiores.2005.10.001","article-title":"The role of natriuretic peptides in cardioprotection","volume":"69","author":"Nishikimi","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0110","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","article-title":"The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial","volume":"380","author":"Solomon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2018.01.077_bb0115","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1472-8206.1999.tb00374.x","article-title":"Valsartan and coronary haemodynamics in early post-myocardial infarction in rats","volume":"13","author":"Gervais","year":"1999","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0120","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0008-6363(02)00667-3","article-title":"Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP","volume":"57","author":"Rosenkranz","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1161\/HYPERTENSIONAHA.113.02164","article-title":"Atrial natriuretic peptide affects cardiac remodeling, function, heart failure, and survival in a mouse model of dilated cardiomyopathy","volume":"63","author":"Wang","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2018.01.077_bb0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure","volume":"347","author":"Maisel","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0135","doi-asserted-by":"crossref","first-page":"H2902","DOI":"10.1152\/ajpheart.2001.280.6.H2902","article-title":"Regional expression of endothelin-1, ANP, IGF-1, and LV wall stress in the infarcted rat heart","volume":"280","author":"Loennechen","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cardiores.2005.06.008","article-title":"Mechanisms of atrial natriuretic peptide secretion from the atrium","volume":"68","author":"Dietz","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0145","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1001\/archinte.163.22.2696","article-title":"Role of the natriuretic peptide system in cardiorenal protection","volume":"163","author":"McFarlane","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0150","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0008-6363(02)00721-6","article-title":"Effect of vasopeptidase inhibitor omapatrilat on cardiomyocyte apoptosis and ventricular remodeling in rat myocardial infarction","volume":"57","author":"Backlund","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0155","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1253\/jcj.62.680","article-title":"Effect of chronic neutral endopeptidase inhibition on cardiac hypertrophy after experimental myocardial infarction","volume":"62","author":"Yoshida","year":"1998","journal-title":"Jpn. Circ. J."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0160","first-page":"3410","article-title":"Effects of angiotensin-converting enzyme inhibition and bradykinin peptides in rats with myocardial infarction","volume":"8","author":"Qu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"Suppl D","key":"10.1016\/j.ijcard.2018.01.077_bb0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/eurheartj\/11.suppl_D.17","article-title":"Relationship between decrease in afterload and beneficial effects of ACE inhibitors in experimental cardiac hypertrophy and congestive heart failure","volume":"11","author":"Michel","year":"1990","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0170","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0735-1097(01)01518-2","article-title":"Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction","volume":"38","author":"Yu","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0175","doi-asserted-by":"crossref","first-page":"C1046","DOI":"10.1152\/ajpcell.00211.2011","article-title":"Decreased metalloprotease 9 induction, cardiac fibrosis, and higher autophagy after pressure overload in mice lacking the transcriptional regulator p8","volume":"301","author":"Georgescu","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0180","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/CIRCRESAHA.109.209189","article-title":"TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation","volume":"106","author":"Kandalam","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0185","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0008-6363(00)00028-6","article-title":"MMP\/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition","volume":"46","author":"Li","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2018.01.077_bb0190","doi-asserted-by":"crossref","first-page":"R683","DOI":"10.1152\/ajpregu.00162.2010","article-title":"Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females","volume":"299","author":"Voloshenyuk","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317354025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317354025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T15:54:02Z","timestamp":1575388442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527317354025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":38,"alternative-id":["S0167527317354025"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.01.077","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.01.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}